Physician profile
Robert Garrett
NPI 1730108572
$5,546.23
in general payments reported to CMS, 2019-2025
14 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,648 · 2020: $474 · 2021: $871 · 2022: $890 · 2023: $999 · 2024: $480 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,662.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,679.54 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $1,492.74 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Acuseal Vascular Graft, Gore Tag Conformable Thoracic Endoprosthesis |
| Silk Road Medical, INC. | $764.07 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cardiovascular Systems INC. | $635.34 | 2019-2023 | Diamondback Coronary |
| Cook Medical LLC | $363.16 | 2020-2025 | Rosen, Zilver Ptx, Cook Celect |
| Boston Scientific Corporation | $346.37 | 2019-2025 | General - Vascular Intervention, General - Angioplasty |
| Philips North America LLC | $76.98 | 2022-2024 | (Br6) Re Entry |
| Medtronic, INC. | $66.79 | 2022 | |
| Abbott Laboratories | $33.48 | 2022-2025 | Viatrac |
| Becton, Dickinson and Company | $22.28 | 2025 | Powerport Clearvue Isp Implantable Port |
| Shockwave Medical, INC | $20.32 | 2021 | |
| Cvrx, INC. | $15.96 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $15.40 | 2022 | |
| Cordis US Corp. | $13.80 | 2023 | Stabilizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.